Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 16:0_16:0_22:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003751 AN006160 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006160 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST002398 AN003905 Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue Muscle Zebrafish Myopathy University of North Carolina at Chapel Hill LC-MS
ST002243 AN003661 Lipidomics analysis of Friedreich's ataxia (FRDA) (part II) Blood Human Friedreichs Ataxia University of Pennsylvania LC-MS
ST001059 AN001733 Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) Adipose tissue Mozambique tilapia Inflammation South East Center for Integrated Metabolomics LC-MS
  logo